Next report date
Report period
H1 2024
EPS estimate
−0.69HKD
Revenue estimate
116.43 MHKD
−848.63 MHKD
192.11 MHKD
380.85 M
Om JW (CAYMAN) THERAPEUTICS CO. LTD
Sektor
Bransch
VD
Yi Ping Li
Webbplats
Huvudkvarter
Shanghai
Employees (FY)
398
Grundat
2017
ISIN
KYG5210T1040
FIGI
BBG00XXS5DK3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
